About Contact Us Careers

Xerostomia Therapeutics Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 2959
Published Date: Dec 26, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Xerostomia Therapeutics Landscape

3M Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Apotex Inc., Church & Dwight Co. Inc.
Colgate-Palmolive Co.
Cumberland Pharmaceuticals Inc.
Daiichi Sankyo Co. Ltd.
Eisai Co. Ltd.
GlaxoSmithKline Plc
Pharmascience Inc.
Quest Products Inc.
Sun Pharmaceutical Industries Ltd.

Browse Key Market Insights with Data Illustration:

Xerostomia Therapeutics Market Size & Share, Growth Report 2037

In the News

Author Credits: Radhika Pawar

Report ID: 2959
Published Date: Dec 26, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of xerostomia therapeutics is evaluated at USD 2.21 billion.

Xerostomia Therapeutics Market size was valued at USD 2.14 billion in 2024 and is set to exceed USD 3.52 billion by 2037, expanding at over 3.9% CAGR during the forecast period i.e., between 2025-2037.

North America industry is set to account for largest revenue share by 2037, due to prominent growth of cases in xerostomia as well as various other diseases associated with dry mouths such as rheumatoid arthritis, HIV, and Sjogren's syndrome.

The major players in the market are 3M Company, Colgate-Palmolive Co., Cumberland Pharmaceuticals Inc., GlaxoSmithKline Plc, Sun Pharmaceutical Industries Ltd., among others.

Inquiry Before Buying Request Free Sample